Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
September 28 2007 - 8:30AM
PR Newswire (US)
WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that the company will present at the Leerink Swann &
Company/MEDACorp Aesthetics Roundtable Conference. Chief Financial
Officer Timothy Baker will discuss Cynosure's business outlook,
growth strategy and recent financial results in a presentation
beginning at 2:10 p.m. ET Wednesday, October 3. The conference will
be held at the Grand Hyatt New York Hotel. Investors interested in
listening to the live webcast of this presentation should log on to
the "Investor Relations" section of Cynosure's website,
http://www.cynosure.com/, and click on the link labeled "Events."
The presentation will be archived on the company's website. About
Leerink Swann & Company Leerink Swann is a healthcare-focused
investment banking firm that provides equity research, corporate
finance, asset management, and strategic advisory services for
institutional, life sciences, and high net worth clients. For the
past six years, Institutional Investor has named Leerink Swann
"Best of the Boutiques" in Healthcare. Through its MEDACorp
division, Leerink Swann provides biomedical-consulting services to
the institutional investment community. With an internal team of
experts and a dedicated external network of academic and
community-based healthcare professionals, MEDACorp assesses the
viability of cutting-edge medical technologies, thus giving
decision makers the information they need to perform. Leerink Swann
is a member NASD/SIPC. For more information, visit
http://www.leerink.com/. About Cynosure, Inc. Cynosure, Inc.
develops and markets aesthetic treatment systems that are used by
physicians and other practitioners to perform non-invasive and
minimally invasive procedures to remove hair, treat vascular
lesions, rejuvenate skin through the treatment of shallow vascular
and pigmented lesions, laser lipolysis and temporarily reduce the
appearance of cellulite. Cynosure's products include a broad range
of laser and other light-based energy sources, including
Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as
intense pulsed light. Cynosure was founded in 1991. For corporate
or product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. Contact Scott Solomon Vice President
Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure,
Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill
Associates, Inc., +1-617-542-5300, Web site:
http://www.cynosure.com/ http://www.leerlink.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Aug 2023 to Aug 2024